In addition, high NEAT1 expression levels in patients with NSCLC (>2 folds of increase, n=67) had a shorter overall survival than that of with low NEAT1 expression levels (≤2 folds of increase, n=29 (Figure 1H), indicating by Kaplan–Meier survival analysis. This evidence concerns the gene NEAT1 and non-small cell lung carcinoma.